Obstetrics and gynecology ·
Miniaturized MIRA robot completes 35 hysterectomies in device trial; super-resolution MRI tested for placenta accreta

Listen to this post
read by AI voices · all episodesTHE SHORT READ
A miniaturized surgical robot, the MIRA Surgical System, performed benign hysterectomy in 35 patients with one conversion in an investigational device exemption trial published Oct. 16 in the Journal of Robotic Surgery. A deep learning MRI study in placenta accreta spectrum also appeared.
THE DETAILS
- Technology Oct 16, 2026Five surgeons used the MIRA Surgical System, described as the first-in-kind miniaturized surgical robotic platform, in a prospective, nonrandomized investigational device exemption trial. One patient required conversion to laparoscopy because of a technical malfunction; mean estimated blood loss was 52.6 mL and mean postoperative stay 5.0 hours. Ten adverse events occurred, two of them intraoperative and device-related, with no Clavien-Dindo grade III or higher events. The authors said larger studies with longer follow-up are required; manufacturer Virtual Incision funded the study, and two authors are its employees.Source: Journal of Robotic Surgery
- AI Oct 11, 2026Researchers in China applied generative adversarial network super-resolution to T2-weighted placental MRI from 245 patients at three institutions and built radiomics models. For placenta accreta spectrum, the super-resolution plus clinical model had areas under the curve of 0.793 and 0.788 in two external validation cohorts, versus 0.654 and 0.652 for standard T2-weighted images, but the model significantly outperformed standard images only in the training cohort, with no significant differences in validation. The retrospective study measured prediction accuracy, not patient outcomes.Source: European Journal of Radiology
The weekly innovation roundup for obstetrics and gynecology, published every Sunday for the week before; every item links to its sources. Latest obstetrics and gynecology news · All specialties